1. Academic Validation
  2. Suppressing Effect of Na+/Ca2+ Exchanger (NCX) Inhibitors on the Growth of Melanoma Cells

Suppressing Effect of Na+/Ca2+ Exchanger (NCX) Inhibitors on the Growth of Melanoma Cells

  • Int J Mol Sci. 2022 Jan 14;23(2):901. doi: 10.3390/ijms23020901.
Zikai Liu 1 Qing Cheng 1 Xiaoli Ma 1 Mingke Song 1
Affiliations

Affiliation

  • 1 Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.
Abstract

The role of calcium ion (CA2+) signaling in tumorigenicity has received increasing attention in melanoma research. Previous CA2+ signaling studies focused on CA2+ entry routes, but rarely explored the role of CA2+ extrusion. Functioning of the Na+/CA2+ exchanger (NCX) on the plasma membrane is the major way of CA2+ extrusion, but very few associations between NCX and melanoma have been reported. Here, we explored whether pharmacological modulation of the NCX could suppress melanoma and promise new therapeutic strategies. Methods included cell viability assay, CA2+ imaging, immunoblotting, and cell death analysis. The NCX inhibitors SN-6 and YM-244769 were used to selectively block reverse operation of the NCX. Bepridil, KB-R7943, and CB-DMB blocked either reverse or forward NCX operation. We found that blocking the reverse NCX with SN-6 or YM-244769 (5-100 μM) did not affect melanoma cells or increase cytosolic CA2+. Bepridil, KB-R7943, and CB-DMB all significantly suppressed melanoma cells with IC50 values of 3-20 μM. Bepridil and KB-R7943 elevated intracellular CA2+ level of melanoma. Bepridil-induced melanoma cell death came from cell cycle arrest and enhanced Apoptosis, which were all attenuated by the CA2+ chelator BAPTA-AM. As compared with melanoma, normal melanocytes had lower NCX1 expression and were less sensitive to the cytotoxicity of bepridil. In conclusion, blockade of the forward but not the reverse NCX leads to CA2+-related cell death in melanoma and the NCX is a potential drug target for Cancer therapy.

Keywords

Ca2+ homeostasis; NCX inhibitors; Na+/Ca2+ exchanger; calcium ions (Ca2+); cell death; drug target; melanocytes; melanoma; pharmacology; vemurafenib.

Figures
Products